sever
acut
respiratori
syndrom
sar
outbreak
realtim
quantit
polymeras
chain
reaction
target
nucleocapsid
gene
end
viral
genom
establish
detect
identifi
sarsassoci
coronaviru
describ
use
assay
screen
clinic
sampl
ever
acut
respiratori
syndrom
sar
new
infecti
diseas
human
first
recogn
late
februari
hanoi
vietnam
diseas
spread
rapidli
case
report
countri
five
contin
month
juli
epidem
result
report
case
global
fatal
rapid
identif
causal
agent
novel
coronaviru
sarscov
repres
extraordinari
achiev
histori
global
health
help
contain
epidem
nonetheless
epidemiolog
pathogenesi
sar
remain
poorli
understood
definit
diagnost
test
specif
treatment
establish
sinc
origin
viru
anim
reservoir
remain
defin
potenti
recurr
unknown
fact
underscor
import
establish
sensit
effici
method
diagnosi
surveil
immunofluoresc
enzymelink
immunosorb
assay
elisa
report
inconsist
detect
antibodi
sarscov
day
onset
symptom
respect
thu
although
help
track
cours
infect
popul
level
serolog
tool
less
use
detect
infect
earli
stage
may
potenti
implement
therapeut
intervent
measur
quarantin
may
reduc
risk
transmiss
person
contrast
polymeras
chain
reaction
pcr
base
assay
potenti
detect
infect
earlier
time
point
describ
sensit
realtim
pcr
assay
readili
standard
across
laboratori
report
use
survey
sampl
person
diagnos
probabl
sar
epidem
beij
primer
probe
select
n
nucleocapsid
protein
gene
region
end
sarscov
genom
use
primer
express
softwar
pe
appli
biosystem
foster
citi
ca
primer
set
use
forward
revers
probe
label
report
fam
quencher
tamra
tib
molbiol
berlin
germani
calibr
standard
gener
pcr
amplif
fragment
compris
part
n
open
read
frame
orf
noncod
region
cata
product
clone
vector
pgemteasi
invitrogen
carlsbad
ca
serial
dilut
linear
plasmid
use
optim
assay
rna
standard
gener
vitro
transcript
linear
plasmid
dna
use
mmessag
mmachin
kit
recommend
manufactur
ambion
austin
tx
portion
construct
nucleotid
n
orf
modifi
site
direct
mutagenesi
distinguish
plasmidderiv
product
authent
product
diagnost
applic
mutat
introduc
g
chang
posit
n
orf
c
chang
posit
creat
uniqu
apai
restrict
site
detect
live
viru
assess
use
supernat
virusinfect
vero
cell
isol
passag
tcid
ml
tenfold
dilut
tissu
cultur
media
rna
aliquot
dilut
extract
resuspend
depctreat
water
revers
transcript
reaction
pcr
viru
dilut
spike
clarifi
supernat
fecal
prepar
simul
clinic
specimen
rna
aliquot
extract
process
clinic
materi
includ
fecal
whole
blood
sampl
collect
chaoyang
hospit
hospit
youan
hospit
xuanwu
hospit
beij
person
diagnosi
probabl
sar
accord
world
health
organ
criteria
analysi
fecal
sampl
g
stool
suspend
ml
phosphatebuff
salin
mix
vigor
centrifug
min
g
supernat
collect
rna
extract
pcr
analysi
analysi
blood
sampl
whole
blood
fraction
use
ficol
paqu
amersham
pharmacia
england
plasma
collect
immunoglobulin
ig
g
igm
level
determin
elisa
kit
beij
genom
institut
beij
china
peripher
blood
mononuclear
cell
collect
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
germani
nine
microlit
total
rna
revers
transcrib
superscript
ii
transcriptas
invitrogen
cdna
subject
pcr
use
taqman
univers
master
mix
kit
pe
appli
biosystem
abi
prism
ht
sequenc
detector
pe
appli
biosystem
thermocycl
condit
min
amperas
ung
min
polymeras
activ
cycl
denatur
min
annealingextens
standard
curv
plasmid
concentr
versu
threshold
cycl
gener
clone
version
termin
portion
viral
genom
correl
coeffici
show
linear
relationship
threshold
cycl
ct
plasmid
concentr
copi
figur
detect
limit
plasmid
dna
copi
per
assay
ct
linear
relationship
consist
obtain
input
load
copi
per
assay
standard
rtpcr
gener
vitro
transcript
rna
linear
plasmid
templat
polymeras
logarithm
dilut
synthes
rna
yield
result
compar
dna
standard
figur
supernat
infect
vero
cell
serial
dilut
determin
detect
limit
live
viru
analysi
rna
extract
logarithm
dilut
indic
detect
threshold
tcid
dilut
tcid
ml
tcid
per
assay
well
threshold
detect
sarscov
spike
fecal
sampl
tcid
dilut
tcid
ml
tcid
per
assay
well
data
shown
materi
person
probabl
sar
includ
fecal
sampl
blood
sampl
control
specimen
collect
outbreak
healthi
person
includ
fecal
sampl
blood
sampl
detect
rate
fecal
sampl
first
day
onset
symptom
tabl
figur
day
follow
detect
rate
declin
even
day
sampl
gave
posit
read
similar
time
cours
observ
analysi
blood
sampl
howev
higher
detect
rate
obtain
note
sampl
match
blood
fece
first
day
onset
symptom
detect
rate
rtpcr
blood
significantli
higher
igm
igg
antibodi
tabl
figur
twentyon
day
onset
symptom
serolog
find
frequent
posit
rtpcr
fecal
blood
sampl
obtain
healthi
person
one
blood
sampl
yield
posit
result
rtpcr
confirm
repeat
assay
sampl
collect
outbreak
may
repres
true
infect
person
yet
symptomat
classic
symptom
clinic
inform
period
sampl
avail
also
analyz
sputum
throatwash
sampl
unrel
cohort
person
diagnosi
probabl
sar
time
onset
symptom
report
rtpcr
detect
rate
obtain
sampl
sputum
sampl
throat
wash
sampl
data
shown
possibl
beij
outbreak
obtain
clinic
materi
prospect
serial
fashion
defin
sarscovinfect
patient
cohort
thu
sampl
repres
person
respiratori
symptom
caus
pathogen
sarscov
howev
confid
clinic
criteria
enhanc
seroposit
sampl
taken
day
onset
symptom
current
realtim
rtpcr
assay
allow
sensit
detect
sarscov
nucleic
acid
clinic
specimen
target
n
gene
sequenc
shown
pol
gene
sequenc
major
advantag
realtim
pcr
platform
amplif
analysi
complet
close
system
thu
risk
contamin
confound
convent
frequent
nest
rtpcr
protocol
markedli
reduc
whether
differ
posit
rate
report
variou
sarscov
assay
reflect
true
differ
assay
perform
mere
differ
specimen
type
differ
sampl
prepar
becom
appar
compar
qualiti
control
test
use
ident
sampl
variou
assay
laboratori
use
calibr
dna
rna
standard
achiev
compar
result
assay
report
new
york
beij
laboratori
rna
integr
critic
determin
sensit
rtpcr
sarscov
assay
sampl
collect
clinic
site
object
nucleic
acid
analysi
addit
protocol
adopt
variou
hospit
sampl
collect
handl
storag
uniform
nonetheless
rtpcr
analysi
result
consist
result
case
match
fece
blood
sampl
furthermor
blood
sampl
seroposit
first
day
onset
symptom
also
posit
rtpcr
rtpcr
posit
sampl
collect
day
onset
symptom
also
seroposit
rtpcr
analysi
blood
less
sensit
index
infect
immunolog
assay
later
time
point
day
onset
symptom
howev
blood
sampl
fecal
sampl
contain
sarscov
rna
day
onset
symptom
similar
durat
persist
sar
sequenc
stool
observ
ren
et
al
whether
infecti
viru
present
later
time
point
remain
total
patient
po
neg
po
neg
po
neg
po
neg
po
neg
fece
pcr
blood
pcr
na
na
blood
igg
na
na
blood
igm
na
na
po
posit
neg
neg
pcr
polymeras
chain
reaction
ig
immunoglobulin
na
avail
determin
nonetheless
find
indic
longterm
monitor
may
requir
control
dissemin
diseas
